Multidrug Therapy for Polycystic Kidney Disease: A Review and Perspective
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multidrug Therapy for Polycystic Kidney Disease: A Review and Perspective
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF NEPHROLOGY
Volume 37, Issue 2, Pages 175-182
Publisher
S. Karger AG
Online
2013-02-15
DOI
10.1159/000346812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation
- (2012) Gianluca Aguiari et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Dose-Dependent Effects of Sirolimus on mTOR Signaling and Polycystic Kidney Disease
- (2012) Z. Novalic et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Somatostatin analog therapy for severe polycystic liver disease: results after 2 years
- (2012) M. C. Hogan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation
- (2011) Justine Elliott et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease
- (2011) Sara Terryn et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer
- (2011) N. Jin et al. CLINICAL CANCER RESEARCH
- Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis
- (2011) Jack T. Lin et al. CLINICAL IMMUNOLOGY
- Mechanism-Based Therapeutics for Autosomal Dominant Polycystic Kidney Disease: Recent Progress and Future Prospects
- (2011) Ming-Yang Chang et al. NEPHRON CLINICAL PRACTICE
- mTOR Inhibitors and Autosomal Dominant Polycystic Kidney Disease
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases
- (2011) Y.-H. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells
- (2010) Nadezhda N. Zheleznova et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Dual inhibition of EGFR and mTOR pathways in small cell lung cancer
- (2010) K Schmid et al. BRITISH JOURNAL OF CANCER
- Clinical effects of calcium channel blockers and renin-angiotensin-aldosterone system inhibitors on changes in the estimated glomerular filtration rate in patients with polycystic kidney disease
- (2010) Michihiro Mitobe et al. Clinical and Experimental Nephrology
- A Pilot Clinical Study to Evaluate Changes in Urine Osmolality and Urine cAMP in Response to Acute and Chronic Water Loading in Autosomal Dominant Polycystic Kidney Disease
- (2010) I. Barash et al. Clinical Journal of the American Society of Nephrology
- Reducing Polycystic Liver Volume in ADPKD: Effects of Somatostatin Analogue Octreotide
- (2010) A. Caroli et al. Clinical Journal of the American Society of Nephrology
- Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney Disease
- (2010) V. E. Torres et al. Clinical Journal of the American Society of Nephrology
- Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways
- (2010) Jinsheng Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease
- (2010) M. C. Hogan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sirolimus Therapy to Halt the Progression of ADPKD
- (2010) N. Perico et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
- (2010) Andreas L. Serra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2010) Gerd Walz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR
- (2010) Ruhee Dere et al. PLoS One
- Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells
- (2009) Gianluca Aguiari et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Polycystin-1 Regulates Extracellular Signal-Regulated Kinase-Dependent Phosphorylation of Tuberin To Control Cell Size through mTOR and Its Downstream Effectors S6K and 4EBP1
- (2009) G. Distefano et al. MOLECULAR AND CELLULAR BIOLOGY
- c-Src Associates with ErbB2 through an Interaction between Catalytic Domains and Confers Enhanced Transforming Potential
- (2009) R. Marcotte et al. MOLECULAR AND CELLULAR BIOLOGY
- Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells
- (2008) G. Aguiari et al. CELL PROLIFERATION
- Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1
- (2008) Sekiya Shibazaki et al. HUMAN MOLECULAR GENETICS
- Triptolide Reduces Cystogenesis in a Model of ADPKD
- (2008) S. J. Leuenroth et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started